HBC April-May 2019 News Bulletin

Tuesday, May 14, 2019

 

Biomedical Sciences Symposium

The second Biomedical Sciences Symposium held on April 18, 2019, was a great success.  Two keynote speakers, Dr. Adam Cohen and Dr. David Keire, as well as six student speakers, gave very informative and interesting presentations.  We thank them all for sharing their time and expertise.

Student Speakers

Student speakers (from left to right):  Wade Henke, Nikola Kenjie, Pamela Johnson, Jordan Hunt, Stephanie Johnson, David Ingham.


Forty posters were presented during the poster session. Congratulations to this year’s poster winners, Mikala Heon, Jeff McFarlane, and Melissa Pressnall.  Abstracts from oral and poster presentations, submitted by the April 12 deadline, as well as pictures of the event, are available for viewing on the Biomedical Sciences Symposium  web page.

We also would like to take this opportunity to thank the students from the Dynamic Aspects of Chemical Biology Training Program and the Biotechnology Training Program who organized this symposium in collaboration with the HBC.  Their great work and dedication was truly appreciated.

 

J.R. & Inez Jay Fund Proposal Submission

We would like to thank everyone who submitted a J.R. & Inez Jay Fund proposal application for consideration.  We received seven proposals this year.   The award recipients will be announced sometime in June.

 

KU NIH Center of Biomedical Research Excellence (CoBRE) in Chemical Biology of Infectious Disease calls for Research Project applications

The KU NIH CoBRE in Chemical Biology of Infectious Disease (CBID) has issued a call for Research Project applications.  The projects must fit with the scientific theme of Chemical Biology of Infectious Disease and make use of at least one of the associated core labs at KU.  Potentially, one project will be funded for a one-year period at up to $140,000 in direct cost with possible renewal for a second period of six months.  A Letter of Intent is due June 15, 2019.   For more information, please consult the announcement.

 

CDMRP Funding Opportunity and Strategies for Success

The Congressionally Directed Medical Research Programs (CDMRP) posted one last webinar in May as part of their webinar series.  The last posted webinar, “Consortium-Type Funding Opportunities,” reviews CDMRP program announcements that focus on establishing consortia for research and/or clinical trials.  Links to past webinar recordings are posted on the webinar schedule page.  All CDMRP program announcements can be found at the Grants.gov (CFDA #12.420) and CDMRP websites, and at the electronic Biomedical Research Application Portal (eBRAP).

 

Have a great summer!

The next HBC News Bulletin edition will not be published until July.   Therefore, the HBC staff would like to take this opportunity to wish everyone a great summer!



Grant Submission Deadlines

March 5, 2021
NIH standard deadline for Research Grants and Cooperative Agreements (R01 and U01) – renewal, resubmission, revision.

March 11, 2021
DoD Breast Cancer Breakthrough Award Levels 1 & 2 & Era of Hope Scholar Award – Pre-application.

March 12, 2021
DoD Breast Cancer Breakthrough Award Levels 3 & 4  & Innovator Award – Pre-application.

March 16, 2021
NIH standard deadline for Other Research Grants and Cooperative Agreements (R03, R21, R33, R21/R33, R34, R36, UH2, UH3, UH2/UH3) – renewal, resubmission, revision.

Recent Awards

Yoshiaki Azuma, Professor, Department of Molecular Biosciences, was awarded $35,000 by the University of Kansas Medical Center Research Institute for his project entitled “Targeting mitotic function of the PICH (Polo-like kinase interacting checkpoint helicase) for novel therapeutics of TNBC.”

Heng Du, Associate Professor, Department of Pharmacology & Toxicology, transferred a grant from  the University of Dallas, Texas.  It is a BrightFocus Foundation project entitled “Synaptic mitochondrial calcium uniporter deregulation and synaptic injury in Alzheimer's disease.”

Teruna Siahaan, Aya and Takeru Higuchi Distinguished Professor and Associate Chair, Department of Pharmaceutical Chemistry, was awarded $25,000 by the PHRMA Foundation as mentor for Kelly Schwinghamer for the project entitled “Non-Invasive Brain Delivery Clearance  and Efficacy of Therapeutic Antibodies in Mice.”

Liang Xu, Professor, Department of Molecular Biosciences, was awarded $35,000 by the University of Kansas Medical Center Research Institute for his project entitled “Drug the Undruggable Musashi Oncoprotein by Fragment-based Drug Discovery.”

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today